185 related articles for article (PubMed ID: 10674158)
1. A survey of fragile X syndrome in a sample from Spanish Basque country.
Arrieta I; Criado B; Martinez B; Telez M; Nuñez T; Peñagarikano O; Ortega B; Lostao CM
Ann Genet; 1999; 42(4):197-201. PubMed ID: 10674158
[TBL] [Abstract][Full Text] [Related]
2. Stability of the FMR1 CGG repeat in a Basque sample.
Arrieta I; Gil A; Nuñez T; Telez M; Martinez B; Criado B; Lostao C
Hum Biol; 1999 Feb; 71(1):55-68. PubMed ID: 9972098
[TBL] [Abstract][Full Text] [Related]
3. Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability.
Patsalis PC; Sismani C; Hettinger JA; Boumba I; Georgiou I; Stylianidou G; Anastasiadou V; Koukoulli R; Pagoulatos G; Syrrou M
Am J Med Genet; 1999 May; 84(3):184-90. PubMed ID: 10331587
[TBL] [Abstract][Full Text] [Related]
4. FRAXA and FRAXE prevalence in patients with nonspecific mental retardation in the Hellenic population.
Syrrou M; Georgiou I; Grigoriadou M; Petersen MB; Kitsiou S; Pagoulatos G; Patsalis PC
Genet Epidemiol; 1998; 15(1):103-9. PubMed ID: 9523214
[TBL] [Abstract][Full Text] [Related]
5. Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.
Guruju MR; Lavanya K; Thelma BK; Sujatha M; OmSai VR; Nagarathna V; Amarjyothi P; Jyothi A; Anandaraj MP
J Clin Neurosci; 2009 Oct; 16(10):1305-10. PubMed ID: 19560928
[TBL] [Abstract][Full Text] [Related]
6. The frequency of fragile X syndrome among selected patients at Songklanagarind Hospital during 1991-1996, studied by cytogenetic and molecular methods.
Jinorose U; Vasiknanonte P; Limprasert P; Brown WT; Panich V
Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():69-74. PubMed ID: 9640603
[TBL] [Abstract][Full Text] [Related]
7. The influence of expanded unmethylated alleles for FRAXA/FRAXE loci in the intellectual performance among Brazilian mentally impaired males.
Barros Santos C; Gonçalves Pimentel MM
Int J Mol Med; 2003 Sep; 12(3):385-9. PubMed ID: 12883656
[TBL] [Abstract][Full Text] [Related]
8. Frequency of the common fragile site at Xq27.2 under conditions of thymidylate stress: implications for cytogenetic diagnosis of the fragile-X syndrome.
Ramos FJ; Emanuel BS; Spinner NB
Am J Med Genet; 1992 Apr; 42(6):835-8. PubMed ID: 1532475
[TBL] [Abstract][Full Text] [Related]
9. 10 years' experience in fragile X testing among mentally retarded individuals in Greece: a molecular and epidemiological approach.
Sofocleous C; Kitsiou S; Fryssira H; Kolialexi A; Kalaitzidaki M; Roma E; Tsangaris GT; Chistofidou C; Metaxotou C; Kanavakis E; Mavrou A
In Vivo; 2008; 22(4):451-5. PubMed ID: 18712171
[TBL] [Abstract][Full Text] [Related]
10. A survey of FRAXE allele sizes in three populations.
Zhong N; Ju W; Curley D; Wang D; Pietrofesa J; Wu G; Shen Y; Pang C; Poon P; Liu X; Gou S; Kajanoja E; Ryynänen M; Dobkin C; Brown WT
Am J Med Genet; 1996 Aug; 64(2):415-9. PubMed ID: 8844095
[TBL] [Abstract][Full Text] [Related]
11. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
Mandel JL; Biancalana V
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and molecular screening for fragile X syndrome in 300 patients with non-specific mental retardation].
Jara L; López M; Mellado C; Aspillaga M; Avendaño I; Blanco R
Rev Med Chil; 1998 Aug; 126(8):911-8. PubMed ID: 9830742
[TBL] [Abstract][Full Text] [Related]
13. Frequency of Fra X syndrome among institutionalized mentally retarded males in Poland.
Mazurczak T; Bocian E; Milewski M; Obersztyn E; Stańczak H; Bal J; Szamotulska K; Karwacki MW
Am J Med Genet; 1996 Jul; 64(1):184-6. PubMed ID: 8826472
[TBL] [Abstract][Full Text] [Related]
14. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population.
Sharma D; Gupta M; Thelma BK
Genet Epidemiol; 2001 Jan; 20(1):129-144. PubMed ID: 11119302
[TBL] [Abstract][Full Text] [Related]
15. Identification of the gene FMR2, associated with FRAXE mental retardation.
Gecz J; Gedeon AK; Sutherland GR; Mulley JC
Nat Genet; 1996 May; 13(1):105-8. PubMed ID: 8673085
[TBL] [Abstract][Full Text] [Related]
16. [From gene to disease; fragile X-syndrome: hereditary mental retardation due to a developmental gene].
de Vries LB; Oostra BA
Ned Tijdschr Geneeskd; 2001 Mar; 145(10):474-6. PubMed ID: 11268909
[TBL] [Abstract][Full Text] [Related]
17. FRAXE mutation analysis in three Spanish families.
Carbonell P; López I; Gabarrón J; Bernabé MJ; Lucas JM; Guitart M; Gabau E; Glover G
Am J Med Genet; 1996 Aug; 64(2):434-40. PubMed ID: 8844099
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathology of the fragile X syndrome.
Tsongalis GJ; Silverman LM
Arch Pathol Lab Med; 1993 Nov; 117(11):1121-5. PubMed ID: 8239933
[TBL] [Abstract][Full Text] [Related]
19. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island.
Gu Y; Shen Y; Gibbs RA; Nelson DL
Nat Genet; 1996 May; 13(1):109-13. PubMed ID: 8673086
[TBL] [Abstract][Full Text] [Related]
20. Implications of fragile X expression in normal males for the nature of the mutation.
Ledbetter DH; Ledbetter SA; Nussbaum RL
Nature; 1986 Nov 13-19; 324(6093):161-3. PubMed ID: 3785381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
